Vaxcyte Interest Income from 2010 to 2024

PCVX Stock  USD 91.70  3.16  3.57%   
Vaxcyte Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income is likely to outpace its year average in 2024. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals
 
Interest Income  
First Reported
2019-03-31
Previous Quarter
21.7 M
Current Value
23.8 M
Quarterly Volatility
8.4 M
 
Covid
Check Vaxcyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers, such as Interest Income of 66.1 M, Interest Expense of 0.0 or Selling General Administrative of 63.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.16. Vaxcyte financial statements analysis is a perfect complement when working with Vaxcyte Valuation or Volatility modules.
  
Check out the analysis of Vaxcyte Correlation against competitors.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

Latest Vaxcyte's Interest Income Growth Pattern

Below is the plot of the Interest Income of Vaxcyte over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Vaxcyte's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxcyte's overall financial position and show how it may be relating to other accounts over time.
Interest Income10 Years Trend
Slightly volatile
   Interest Income   
       Timeline  

Vaxcyte Interest Income Regression Statistics

Arithmetic Mean9,378,557
Geometric Mean606,605
Coefficient Of Variation239.65
Mean Deviation14,693,632
Median155,000
Standard Deviation22,475,783
Sample Variance505.2T
Range65.9M
R-Value0.63
Mean Square Error330.5T
R-Squared0.39
Significance0.01
Slope3,148,298
Total Sum of Squares7072.3T

Vaxcyte Interest Income History

202466.1 M
202362.9 M
20228.4 M
2021344 K
2020244 K
2019632 K
2018903 K

Other Fundumenentals of Vaxcyte

Vaxcyte Interest Income component correlations

0.990.99-0.990.54-0.73-0.730.880.521.00.960.87-0.67-0.761.00.880.990.820.930.84
0.991.0-0.980.54-0.69-0.690.890.420.990.970.88-0.64-0.781.00.890.990.830.920.85
0.991.0-0.970.57-0.74-0.740.910.441.00.980.89-0.69-0.821.00.911.00.860.890.86
-0.99-0.98-0.97-0.510.750.75-0.88-0.57-0.97-0.96-0.90.690.68-0.98-0.88-0.96-0.82-0.96-0.87
0.540.540.57-0.51-0.7-0.70.740.30.570.660.36-0.69-0.610.560.690.550.760.390.36
-0.73-0.69-0.740.75-0.71.0-0.86-0.63-0.75-0.83-0.741.00.65-0.74-0.82-0.73-0.84-0.62-0.73
-0.73-0.69-0.740.75-0.71.0-0.86-0.63-0.75-0.83-0.741.00.65-0.74-0.82-0.73-0.84-0.62-0.73
0.880.890.91-0.880.74-0.86-0.860.40.890.970.89-0.84-0.740.90.950.880.970.790.86
0.520.420.44-0.570.3-0.63-0.630.40.50.460.41-0.6-0.260.470.450.460.40.530.42
1.00.991.0-0.970.57-0.75-0.750.890.50.970.87-0.7-0.821.00.91.00.840.90.84
0.960.970.98-0.960.66-0.83-0.830.970.460.970.91-0.79-0.780.980.950.960.930.880.89
0.870.880.89-0.90.36-0.74-0.740.890.410.870.91-0.71-0.610.890.870.860.840.860.98
-0.67-0.64-0.690.69-0.691.01.0-0.84-0.6-0.7-0.79-0.710.64-0.69-0.8-0.68-0.83-0.55-0.7
-0.76-0.78-0.820.68-0.610.650.65-0.74-0.26-0.82-0.78-0.610.64-0.79-0.8-0.85-0.76-0.48-0.64
1.01.01.0-0.980.56-0.74-0.740.90.471.00.980.89-0.69-0.790.90.990.850.920.86
0.880.890.91-0.880.69-0.82-0.820.950.450.90.950.87-0.8-0.80.90.90.990.750.91
0.990.991.0-0.960.55-0.73-0.730.880.461.00.960.86-0.68-0.850.990.90.840.870.84
0.820.830.86-0.820.76-0.84-0.840.970.40.840.930.84-0.83-0.760.850.990.840.70.87
0.930.920.89-0.960.39-0.62-0.620.790.530.90.880.86-0.55-0.480.920.750.870.70.79
0.840.850.86-0.870.36-0.73-0.730.860.420.840.890.98-0.7-0.640.860.910.840.870.79
Click cells to compare fundamentals

About Vaxcyte Financial Statements

Vaxcyte investors use historical fundamental indicators, such as Vaxcyte's Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaxcyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Income62.9 M66.1 M
Net Interest Income62.9 M66.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.